Across LMICs, access to effective treatments varies widely, including for conditions such as epilepsy, schizophrenia and dementia. Many of these medicines are both affordable and clinically effective, yet they remain out of reach for the people who need them most.
Managing medicine supply is a longstanding challenge. Health systems face rising demand, limited staffing and fragmented supply chains. Gaps in data and weak forecasting make it difficult to manage supply and demand, leading to wasted stock in some areas and critical shortages in others.
The problem is particularly acute in mental and neurological health, where access is limited and stigma remains widespread. Without reliable access to treatment, people face avoidable deterioration in health, lost opportunities for education and work, and significant strain on families and communities.
The Oxford Martin Programme on the Equitable Allocation of Medicines is developing a digital tool to support more effective and equitable delivery of essential medicines. Working with the World Health Organization, the Clinton Health Access Initiative, and partners in Zimbabwe, the team is creating a Medication Availability Tracking Tool that uses real-time data and AI-powered forecasting to improve distribution.
Designed for use in settings with limited digital infrastructure, the tool supports local decision-making and aims to strengthen health systems without adding complexity. While the pilot focuses on mind and brain health in Zimbabwe, the system is designed to be flexible and scalable, with the potential to improve healthcare access for millions across conditions and regions.
Find out more about the Oxford Martin Programme on the Equitable Allocation of Medicines.